Contact Us

Impact Analysis of Covid-19

The complete version of the Report will include the impact of the COVID-19, and anticipated change on the future outlook of the industry, by taking into the account the political, economic, social, and technological parameters.

Europe Pharmaceutical Drugs Market

Pharmaceutical drugs are used for treatment of chronic and acute diseases. There are two types of pharmaceutical drugs, generic and branded, which are sold through prescription and over the counter (OTC). Generic drugs are similar to branded drugs and are less expensive as compared to branded drugs.

Increasing prevalence of diseases such as cardiovascular disorders, cancer, and metabolic disorders, as well as product launches, patent expiry of branded drugs and other diseases and presence of favorable reimbursement policies are expected to increase demand for pharmaceutical drugs market in Europe during the forecast period.

The Europe pharmaceutical drugs market size was estimated to be valued at US$ 152.1 billion in 2019, and is expected to exhibit a CAGR of 4.5% over the forecast period (2019–2027).

Figure 1. Europe Pharmaceutical Drugs Market Share (%), by Europe, 2019

Europe Pharmaceutical Drugs  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

Increasing incidence and prevalence of diseases to fuel the demand in Europe Pharmaceutical Drugs Market

Increasing prevalence of cancer, diabetes and other diseases in European region is expected to increase demand for efficient diabetes drugs during the forecast period. For instance, according to the International Diabetes Foundation’s 2019 report, an estimated 59,322 individuals were diagnosed with diabetes and around 9,500 were diagnosed in Germany in the same year.

Moreover, increasing prevalence of cancer is also expected to propel the growth of the market during the forecast period. For instance, in 2019, according to the European Commission reports the estimated number of new cancer cases in 28 European countries was 1.6 million in males and 1.4 million in females

Figure 2. Europe Pharmaceutical Drugs Market Share (%), by Product Type,(2019-2027)

Europe Pharmaceutical Drugs  | Coherent Market Insights

Source: Coherent Market Insights Analysis (2020)

Increasing product launch and increasing research has been the major driving factors propelling growth of the Europe Pharmaceutical Drugs Market

Increasing patient population has resulted in increased demand for new and efficient drug products for treatment of various diseases. Therefore, in order to cope up with rising demand, manufacturers of pharmaceutical drugs are investing in product developments to launch novel drug product. For instance, in July 2019, Sandoz, a subsidiary of Novartis AG, launched generic oncology medicine Gefitinib for adult patients with locally advanced or metastatic non-small cell lung cancer across 13 European countries.

Key Players

Major players operating in the Europe Pharmaceutical Drugs market include, Allergan plc. , Novo Nordisk, Boehringer Ingelheim, Merck KGaA, GlaxoSmithKline Plc., AstraZeneca Plc., Baxter AG, Novartis AG, F. Hoffmann-La Roche Ltd, Shire, and Sanofi.

Pharmaceutical drugs are composed of chemical compounds which are used for prevention and treatment of diseases and are administered intravenously, orally, intramuscularly, and other routes of administration. Pharmaceutical drugs are of two types; generic and branded. Pharmaceutical drugs are subjected to numerous regulations with respect to patenting, clinical trial, drug safety, efficacy and marketing in European region.

Market Dynamics

Patent expiry of branded products is paving the entry for generics drugs in the market. Moreover, product launches along with increasing healthcare expenditure are major factors that are driving the global Europe pharmaceutical drugs market growth.

For instance, Cetuximab (Erbitux) is an epidermal growth factor receptor inhibitor indicated for the treatment of metastatic colorectal cancer and head and neck cancer. It is manufactured under the patent by Bristol-Myers Squibb and Eli Lily Company in Europe. The drug’s patent expires in 2018, and thus, is expected to provide opportunity for a large number of market players to manufacture generic versions.

Furthermore, adoption of inorganic and organic strategies such as mergers and acquisitions, and product developments by key players to expand their product portfolio is expected to drive the market growth. For instance, on January 2020, Novartis AG received European Commission’s approval for MAyznet for treatment of secondary progressive multiple sclerosis (SPMS) in adult patients.

Key features of the study:

  • This report provides in-depth analysis of the Europe Pharmaceutical Drugs market  and provides market size (US$ million) and compound annual growth rate (CAGR %) for the forecast period (2019–2027), considering 2018 as the base year
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends,  regional outlook, and competitive strategy adopted by key players
  • It profiles key players in the global Europe Pharmaceutical Drugs market  based on the following parameters – company overview, financial performance, product portfolio, market presence, distribution strategies, key developments, strategies, and future plans
  • Key companies covered as a part of this study include, Allergan plc. , Novo Nordisk, Boehringer Ingelheim, Merck KGaA, GlaxoSmithKline Plc. , AstraZeneca Plc, Baxter AG, Novartis AG, F. Hoffmann-La Roche Ltd, Shire, and Sanofi
  • Insights from this report would allow marketers and management authorities of the companies to make informed decisions regarding future product launches, technology up-gradation, market expansion, and marketing tactics
  • The global Europe Pharmaceutical Drugs market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global Europe Pharmaceutical Drugs market

Detailed Segmentation:

  • Europe Pharmaceutical Drugs Market, By Drug Type:
    • Generic Drugs
    • Branded Drugs
  • Global Europe Pharmaceutical Drugs Market, By Product Type:
    • Prescription Drugs
    • Over-the-counter (OTC) Drugs
  • Global Europe Pharmaceutical Drugs Market, By Application:
    • Cardiovascular         
    • Musculoskeletal
    • Oncology
    • Anti-infective
    • Metabolic Disorder
    • Central Nervous System
    • Genito-urinary
    • Gastrointestinal
    • Respiratory
    • Hematology
    • Dermatology
    • Ophthalmology
    • Others
  • Global Europe Pharmaceutical Drugs Market, By Distribution Channel:
    • Hospital Pharmacy
    • Retail Pharmacy
    • Online Pharmacy
  • Global Europe Pharmaceutical Drugs Market, By Country/Region:
    • U.K.
      • By Drug Type:
        • Generic Drugs
        • Branded Drugs
      • By Product Type:
        • Prescription Drugs
        • Over-the-counter (OTC) Drugs
      • By Application
        • Cardiovascular         
        • Musculoskeletal
        • Oncology
        • Anti-infective
        • Metabolic Disorder
        • Central Nervous System
        • Genito-urinary
        • Gastrointestinal
        • Respiratory
        • Hematology
        •  Dermatology
        • Ophthalmology
        • Others
      • By Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • Germany
      • By Drug Type:
        • Generic Drugs
        • Branded Drugs
      • By Product Type:
        • Prescription Drugs
        • Over-the-counter (OTC) Drugs
      • By Application
        • Cardiovascular         
        • Musculoskeletal
        • Oncology
        • Anti-infective
        • Metabolic Disorder
        • Central Nervous System
        • Genito-urinary
        • Gastrointestinal
        • Respiratory
        • Hematology
        •  Dermatology
        • Ophthalmology
        • Others
      • By Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • France
      • By Drug Type:
        • Generic Drugs
        • Branded Drugs
      • By Product Type:
        • Prescription Drugs
        • Over-the-counter (OTC) Drugs
      • By Application
        • Cardiovascular         
        • Musculoskeletal
        • Oncology
        • Anti-infective
        • Metabolic Disorder
        • Central Nervous System
        • Genito-urinary
        • Gastrointestinal
        • Respiratory
        • Hematology
        •  Dermatology
        • Ophthalmology
        • Others
      • By Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • Italy
      • By Drug Type:
        • Generic Drugs
        • Branded Drugs
      • By Product Type:
        • Prescription Drugs
        • Over-the-counter (OTC) Drugs
      • By Application
        • Cardiovascular         
        • Musculoskeletal
        • Oncology
        • Anti-infective
        • Metabolic Disorder
        • Central Nervous System
        • Genito-urinary
        • Gastrointestinal
        • Respiratory
        • Hematology
        • Dermatology
        • Ophthalmology
        • Others
      • By Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • Spain
      • By Drug Type:
        • Generic Drugs
        • Branded Drugs
      • By Product Type:
        • Prescription Drugs
        • Over-the-counter (OTC) Drugs
      • By Application
        • Cardiovascular         
        • Musculoskeletal
        • Oncology
        • Anti-infective
        • Metabolic Disorder
        • Central Nervous System
        • Genito-urinary
        • Gastrointestinal
        • Respiratory
        • Hematology
        • Dermatology
        • Ophthalmology
        • Others
      • By Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • Russia
      • By Drug Type:
        • Generic Drugs
        • Branded Drugs
      • By Product Type:
        • Prescription Drugs
        • Over-the-counter (OTC) Drugs
      • By Application
        • Cardiovascular         
        • Musculoskeletal
        • Oncology
        • Anti-infective
        • Metabolic Disorder
        • Central Nervous System
        • Genito-urinary
        • Gastrointestinal
        • Respiratory
        • Hematology
        • Dermatology
        • Ophthalmology
        • Others
      • By Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • Netherlands
      • By Drug Type:
        • Generic Drugs
        • Branded Drugs
      • By Product Type:
        • Prescription Drugs
        • Over-the-counter (OTC) Drugs
      • By Application
        • Cardiovascular         
        • Musculoskeletal
        • Oncology
        • Anti-infective
        • Metabolic Disorder
        • Central Nervous System
        • Genito-urinary
        • Gastrointestinal
        • Respiratory
        • Hematology
        • Dermatology
        • Ophthalmology
        • Others
      • By Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • Poland
      • By Drug Type:
        • Generic Drugs
        • Branded Drugs
      • By Product Type:
        • Prescription Drugs
        • Over-the-counter (OTC) Drugs
      • By Application
        • Cardiovascular         
        • Musculoskeletal
        • Oncology
        • Anti-infective
        • Metabolic Disorder
        • Central Nervous System
        • Genito-urinary
        • Gastrointestinal
        • Respiratory
        • Hematology
        • Dermatology
        • Ophthalmology
        • Others
      • By Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • Switzerland
      • By Drug Type:
        • Generic Drugs
        • Branded Drugs
      • By Product Type:
        • Prescription Drugs
        • Over-the-counter (OTC) Drugs
      • By Application
        • Cardiovascular         
        • Musculoskeletal
        • Oncology
        • Anti-infective
        • Metabolic Disorder
        • Central Nervous System
        • Genito-urinary
        • Gastrointestinal
        • Respiratory
        • Hematology
        • Dermatology
        • Ophthalmology
        • Others
      • By Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • Sweden
      • By Drug Type:
        • Generic Drugs
        • Branded Drugs
      • By Product Type:
        • Prescription Drugs
        • Over-the-counter (OTC) Drugs
      • By Application
        • Cardiovascular         
        • Musculoskeletal
        • Oncology
        • Anti-infective
        • Metabolic Disorder
        • Central Nervous System
        • Genito-urinary
        • Gastrointestinal
        • Respiratory
        • Hematology
        • Dermatology
        • Ophthalmology
        • Others
      • By Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
    • Rest of Europe
      • By Drug Type:
        • Generic Drugs
        • Branded Drugs
      • By Product Type:
        • Prescription Drugs
        • Over-the-counter (OTC) Drugs
      • By Application
        • Cardiovascular         
        • Musculoskeletal
        • Oncology
        • Anti-infective
        • Metabolic Disorder
        • Central Nervous System
        • Genito-urinary
        • Gastrointestinal
        • Respiratory
        • Hematology
        • Dermatology
        • Ophthalmology
        • Others
      • By Distribution Channel
        • Hospital Pharmacy
        • Retail Pharmacy
        • Online Pharmacy
  • Company Profiles
    • Allergan plc. *
      • Company Overview
      • Product Portfolio
      • Financial Performance
      • Key Highlights
      • Market Strategies
    • Novo Nordisk
    • Boehringer Ingelheim
    • Merck KGaA
    • GlaxoSmithKline Plc.
    • AstraZeneca Plc
    • Baxter AG
    • Novartis AG
    • Hoffmann-La Roche Ltd
    • Shire
    • Sanofi

“*” marked represents similar segmentation in other categories in the respective section.

Table of Contents

  1. Research Objectives and Assumptions
    • Research Objectives
    • Assumptions
    • Abbreviations
  2. Market Purview
    • Report Description
      • Market Definition and Scope
    • Executive Summary
      • Market Snippet, By Drug Type
      • Market Snippet, By Product Type
      • Market Snippet, By Application
      • Market Snippet, By Distribution Channel
      • Market Snippet, By Country/Region
    • Coherent Opportunity Map (COM)
  3. Market Dynamics, Regulations, and Trends Analysis
    • Market Dynamics
      • Drivers
      • Restraints
      • Market Opportunities
    • Impact Analysis
    • Key Developments
    • Industry Trends
    • Regulatory Scenario
    • Reimbursement Scenario
    • Epidemiology
    • PEST Analysis
  4. Europe Pharmaceutical Drugs Market, By Drug Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Generic Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Branded Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  5. Europe Pharmaceutical Drugs Market, By Product Type, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Prescription Drugs
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Over-the-counter (OTC) Drugs
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  6. Europe Pharmaceutical Drugs Market, By Application, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Cardiovascular
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Musculoskeletal
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Oncology
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Anti-infective
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Metabolic Disorder
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Central Nervous System
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Genito-urinary
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Gastrointestinal
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Respiratory
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Hematology
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Dermatology
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Ophthalmology
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Others
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  7. Europe Pharmaceutical Drugs Market, By Distribution Channel, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, 2017 – 2027
      • Segment Trends
    • Hospital Pharmacies
      •  Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Retail Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
    • Online Pharmacies
      • Introduction
      • Market Size and Forecast, and Y-o-Y Growth, 2016 – 2027, (US$ Mn)
  8. Europe Pharmaceutical Drugs Market, By Country, 2019 – 2027, (US$ Mn)
    • Introduction
      • Market Share Analysis, By Region, 2019 and 2027 (%)
      • Y-o-Y Growth Analysis, For Regions, 2017–2026
    • U.K.
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • Germany
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • France
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • Italy
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • Spain
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • Russia
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • Netherlands
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • Poland
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • Switzerland
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • Sweden
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
    • Rest of Europe
      • Market Size and Forecast, By Drug Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Product Type, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Application, 2016 – 2027, (US$ Mn)
      • Market Size and Forecast, By Distribution Channel, 2016 – 2027, (US$ Mn)
  9. Competitive Landscape
    • Company Profiles
      • Allergan plc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Novo Nordisk
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Boehringer Ingelheim
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Merck KGaA
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      •  GlaxoSmithKline Plc.
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • AstraZeneca Plc
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Baxter AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Novartis AG
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • F. Hoffmann-La Roche Ltd
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Shire
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
      • Sanofi
        • Company Overview
        • Product Portfolio
        • Financial Overview
        • Key Highlights
        • Market Strategies
  10. Section
    • References
    • Research Methodology
    • About us and Sales Contact

*Browse 30 market data tables and 38 figures on "Pharmaceutical Drugs Market - Europe forecast to 2027”.

Existing Clientele

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients

Our Trusted Patner